https://www.selleckchem.com/pr....oducts/namodenoson-c
ion fidelity and economic indicators will be analyzed. This trial is designed to explore the feasibility and acceptability of a new model of shared care for lymphoma survivors. Patient-reported outcomes as well as potential barriers to implementation will be analyzed to inform a larger definitive clinical trial testing the effects and implementationof a shared care model on health-related quality of life of lymphoma survivors. Australia and New Zealand Clinical Trials Registry ACTRN12620000594921 . Registered on 22 May 2020.
Like
Comment
Share
